Morena Gavrić, MD

Morena Gavrić, MD, graduated from the University of Sarajevo School of Medicine and passed her specialist examination in ophthalmology at the University Hospital Center Zagreb (Rebro).

She completed her postgraduate studies in “Ultrasound in Clinical Medicine” at the School of Medicine, University of Zagreb.

She passed her subspecialist exam in glaucoma in Zagreb.

• Head of the Glaucoma Department at the Special Hospital for Ophthalmology Svjetlost
• Glaucoma Subspecialist

Dr. Morena Gavrić specializes in the diagnosis and treatment of glaucoma, as well as the diagnosis and treatment of certain corneal conditions (keratoconus).

In glaucoma, she uses the most advanced diagnostic methods, and in treatment, she employs lasers, including the latest PLT (pattern laser trabeculoplasty).

For keratoconus diagnosis, she uses top-tier diagnostic equipment, and for treating the disease, she applies Collagen Crosslinking.

She was the first in Croatia to implement Selective Laser Trabeculoplasty (SLT) in glaucoma treatment.

She is also the first to apply PLT (pattern laser trabeculoplasty).

She is a member of the Croatian Ophthalmological Society, the Croatian Society for Cataract and Refractive Surgery (CSCRS), and the European Glaucoma Society.

• Selective laser trabeculoplasty in the treatment of Pseudoexfoliation glaucoma in patients allergic to all antiglaucoma drops – Morena Gavrić; Nikica Gabrić; Iva Dekaris; Maja Bohač; Nataša Drača
• Clinical Experience with Ex-press mini glaucoma shunt implantation – Morena Gavrić; Nikica Gabrić; Jurica Jagić; Ana Čović
• Multifocal intraocular lenses in cataract surgery and refractive surgery – Ante Barišić; Nikica Gabrić; Iva Dekaris; Morena Gavrić; Ivana Mravičić; Ivana Romac; Maja Bohač
• Biomaterial infections in ophthalmology – Iva Dekaris; Nikica Gabrić; Morena Gavrić; Ratimir Lazić
• Photodynamic therapy combined with intravitreal bevacizumab (Avastin) in treatment of choroidal neovascularization secondary to age related macular degeneration -Lazić R; Gabrić N; Dekaris I; Gavrić M; Bosnar D
• Intravitreal bevacizumab(Avastin) in treatment of neovascular age related macular degeneration -Lazić R; Gabrić N; Dekaris I; Šarić B; Gavrić M

[email protected]